A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes: A randomized, controlled trial

T. Heise; C. J. Tack; R. Cuddihy; J. Davidson; D. Gouet; A. Liebl; E. Romero; H. Mersebach; P. Dykiel; R. Jorde

doi:10.2337/dc10-1905

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes: A randomized, controlled trial

Diabetes Care ◽

10.2337/dc10-1905 ◽

2011 ◽

Vol 34 (3) ◽

pp. 669-674 ◽

Cited By ~ 66

Author(s):

T. Heise ◽

C. J. Tack ◽

R. Cuddihy ◽

J. Davidson ◽

D. Gouet ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Long Acting ◽

New Generation

Download Full-text

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Diabetes Care ◽

10.2337/dc14-0990 ◽

2014 ◽

Vol 37 (12) ◽

pp. 3235-3243 ◽

Cited By ~ 169

Author(s):

Hannele Yki-Järvinen ◽

Richard Bergenstal ◽

Monika Ziemen ◽

Marek Wardecki ◽

Isabel Muehlen-Bartmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Glucose Control ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Oral Agents

Download Full-text

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12618 ◽

2016 ◽

Vol 18 (4) ◽

pp. 366-374 ◽

Cited By ~ 67

Author(s):

Y. Terauchi ◽

M. Koyama ◽

X. Cheng ◽

Y. Takahashi ◽

M. C. Riddle ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Glucose Control ◽

Basal Insulin ◽

Controlled Trial ◽

Japanese People ◽

Randomized Controlled ◽

Antihyperglycaemic Drugs

Download Full-text

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc20-2877 ◽

2021 ◽

pp. dc202877

Author(s):

Harpreet S. Bajaj ◽

Richard M. Bergenstal ◽

Andreas Christoffersen ◽

Melanie J. Davies ◽

Amoolya Gowda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Basal Insulin ◽

Controlled Trial ◽

Phase 2 ◽

Once Daily ◽

Randomized Controlled ◽

Daily Insulin

Download Full-text

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14354 ◽

2021 ◽

Cited By ~ 1

Author(s):

Rory J. McCrimmon ◽

Saud Al Sifri ◽

Rifat Emral ◽

Viswanathan Mohan ◽

Leobardo Sauque‐Reyna ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Baseline Characteristics

Download Full-text

Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13806 ◽

2019 ◽

Vol 21 (10) ◽

pp. 2327-2332 ◽

Cited By ~ 2

Author(s):

Sylvia Franc ◽

Michael Joubert ◽

Ahmed Daoudi ◽

Cédric Fagour ◽

Pierre‐Yves Benhamou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Glycaemic Control ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Initiation ◽

Randomized Controlled

Download Full-text

Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

Diabetes Care ◽

10.2337/dc13-0038 ◽

2013 ◽

Vol 36 (7) ◽

pp. e106-e106

Author(s):

P. D. Home

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Diabetes Care ◽

Basal Insulin ◽

Randomized Controlled Study ◽

Controlled Study ◽

Once Daily ◽

Randomized Controlled ◽

Long Acting

Download Full-text

Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial

Diabetes & Metabolism Journal ◽

10.4093/dmj.2020.0274 ◽

2021 ◽

Author(s):

Jae Hyun Bae ◽

Chang Ho Ahn ◽

Ye Seul Yang ◽

Sun Joon Moon ◽

Soo Heon Kwak ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Titration Study

Download Full-text

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1745 ◽

2020 ◽

Vol 43 (5) ◽

pp. 1085-1093 ◽

Cited By ~ 7

Author(s):

W. Timothy Garvey ◽

Andreas L. Birkenfeld ◽

Dror Dicker ◽

Geltrude Mingrone ◽

Sue D. Pedersen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Basal Insulin ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Overweight Or Obesity

Download Full-text

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672–1680

Diabetes Care ◽

10.2337/dc19-er08 ◽

2019 ◽

Vol 42 (8) ◽

pp. 1604.1-1604

Author(s):

Robert Ritzel ◽

Stewart B. Harris ◽

Helen Baron ◽

Hermes Florez ◽

Ronan Roussel ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Older People ◽

Insulin Glargine ◽

Diabetes Care ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text